TipRanks on MSN

Travere Therapeutics’ Study on Homocystinuria: A Closer Look at the ACAPPELLA Study

Travere Therapeutics, Inc. (($TVTX)) announced an update on their ongoing clinical study. Travere Therapeutics, Inc. is conducting a study titled ...
Seeking Alpha

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in preclinical models and healthy volunteer study ...
ZAWYA

Denovo Sciences, Sidra Medicine, and Weill Cornell Medicine-Qatar announce collaboration to discover drug candidates for Homocystinuria

Established by the Qatar Foundation for Education, Science, and Community Development, Sidra Medicine is committed to ...
Seeking Alpha

Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to ...

AUSTIN, Texas, April 12, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare ...